Vimarsana
Biggest News Aggregation in the World

Cell Therapy Trials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Therapy Trials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Therapy Trials Today - Breaking & Trending Today

Editas Medicine Presents Data on SLEEK Gene Editing Technology at the American Society of Gene and Cell Therapy Annual Meeting - Vimarsana News

Editas Medicine Presents Data on SLEEK Gene Editing Technology at the American Society of Gene and Cell Therapy Annual Meeting

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Genascence Announces Data From Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, Presented at American Society of Gene & Cell Therapy 25th Annual Meeting - Vimarsana News

Genascence Announces Data From Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, Presented at American Society of Gene & Cell Therapy 25th Annual Meeting

/PRNewswire/ -- Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal...

AskBio to Present 11 Abstracts at Upcoming American Society of Gene and Cell Therapy's 25th Annual Meeting - Vimarsana News

AskBio to Present 11 Abstracts at Upcoming American Society of Gene and Cell Therapy's 25th Annual Meeting

/PRNewswire/ -- Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, today announced that the Company...

Nanoscope's Clinical and Scientific Advancesin Optogenetics to be Featured at ASGCT Annual Meeting, May 16-19, 2022 in Washington, DC - Vimarsana News

Nanoscope's Clinical and Scientific Advancesin Optogenetics to be Featured at ASGCT Annual Meeting, May 16-19, 2022 in Washington, DC

/PRNewswire/ -- Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing optogenetic therapies for treatment of retinal degenerative...

Genascence Announces First Close in Series A Financing led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board - Vimarsana News

Genascence Announces First Close in Series A Financing led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board

Proceeds will be used to advance clinical program of GNSC-001, company's lead candidate in osteoarthritis (OA) Brian Kotzin, M.D., and Jackson Streeter, M.D.,...